|
1
|
Mikhail A, Brown C, Williams JA, Mathrani
V, Shrivastava R, Evans J, Isaac H and Bhandari S: Renal
association clinical practice guideline on Anaemia of chronic
kidney disease. BMC Nephrol. 18(345)2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Babitt JL, Eisenga MF, Haase VH,
Kshirsagar AV, Levin A, Locatelli F, Małyszko J, Swinkels DW, Tarng
DC, Cheung M, et al: Controversies in optimal anemia management:
conclusions from a kidney disease: Improving global outcomes
(KDIGO) conference. Kidney Int. 99:1280–1295. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Young NS and Brown KE: Parvovirus B19. N
Engl J Med. 350:586–597. 2004.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Duranay M, Bali M, Sahin M, Yakinci G,
Vurgun N and Dilmen U: Parvovirus B19 infection and
unresponsiveness to erythropoietin therapy in Haemodialysis
patients. Nephrol Dial Transplant. 13:779–780. 1998.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ozeki M, Fukushima T, Ohzeki M, Sasaki T
and Kashihara N: A nosocomial parvovirus B19 infection-induced
transient aplastic crisis in a patient with chronic renal failure.
Clin Nephrol. 65:141–143. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
6
|
Shi Y, Shi X, Wang H, Zhou Z, Zhang L and
Chen L: Pure red cell aplasia secondary to parvovirus B19 infection
as a rare cause of anemia in a dialysis patient. Intern Med.
63:2647–2650. 2024.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Evangelista L, Panunzio A, Polverosi R,
Ferretti A, Chondrogiannis S, Pomerri F, Rubello D and Muzzio PC:
Early bone marrow metastasis detection: The additional value of
FDG-PET/CT vs. CT imaging. Biomed Pharmacother. 66:448–453.
2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kitajima K, Yamamoto S, Fukushima K,
Yamakado K, Katsuura T, Igarashi Y, Kawanaka Y, Mouri M and Hirota
S: FDG-PET/CT as a post-treatment restaging tool in urothelial
carcinoma: Comparison with contrast-enhanced CT. Eur J Radiol.
85:593–598. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Guillen E, Hermida E, Rodas L, Broseta JJ
and Cases A: Aplastic crisis secondary to parvovirus B19
primoinfection as an infrequent cause of anemia in an
immunocompetent, non-dialysis chronic kidney disease patient. Clin
Nephrol. 95:224–226. 2021.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Schröder C, Roeles J, Schwarzer A, Heuser
M, Retzlaff J and Hiß M: Treatment-refractory anaemia in a
35-year-old heart transplant recipient on chronic hemodialysis.
Internist (Berl). 62:768–771. 2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Eleftheriadis T, Antoniadi G, Liakopoulos
V, Kartsios C and Stefanidis I: Basic science and dialysis:
Disturbances of acquired immunity in hemodialysis patients. Semin
Dial. 20:440–451. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Broliden K, Tolfvenstam T and Norbeck O:
Clinical aspects of parvovirus B19 infection. J Intern Med.
260:285–304. 2006.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Landry ML: Parvovirus B19. Microbiol
Spectr. 4(DMIH2-0008-2015)2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Maple PAC, Hedman L, Dhanilall P, Kantola
K, Nurmi V, Söderlund-Venermo M, Brown KE and Hedman K:
Identification of past and recent parvovirus B19 infection in
immunocompetent individuals by quantitative PCR and enzyme
immunoassays: A dual-laboratory study. J Clin Microbiol.
52:947–956. 2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Eleftheriadis T, Divani M, Leontaridis T,
Poulianiti C, Polyzou-Konsta MA, Lykotsetas E and Stefanidis I:
Parvovirus B19-induced pure red cell aplasia several years after
kidney transplantation and following a transition from everolimus
to tacrolimus. Exp Clin Transplant. 23:67–71. 2025.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Eid AJ and Ardura MI: AST Infectious
Diseases Community of Practice. Human parvovirus B19 in solid organ
transplantation: Guidelines from the American society of
transplantation infectious diseases community of practice. Clin
Transplant. 33(e13535)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kidney Disease; Improving Global Outcomes
(KDIGO) Anemia Work Group. KDIGO 2026 clinical practice guideline
for the management of anemia in chronic kidney disease (CKD).
Kidney Int. 109:S1–S99. 2026.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Karaboyas A, Morgenstern H, Fleischer NL,
Vanholder RC, Dhalwani NN, Schaeffner E, Schaubel DE, Akizawa T,
James G, Sinsakul MV, et al: Inflammation and
erythropoiesis-stimulating agent response in hemodialysis patients:
A self-matched longitudinal study of anemia management in the
dialysis outcomes and practice patterns study (DOPPS). Kidney Med.
2:286–296. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Crabol Y, Terrier B, Rozenberg F, Pestre
V, Legendre C, Hermine O, Montagnier-Petrissans C, Guillevin L and
Mouthon L: Groupe d'experts de l'Assistance Publique-Hôpitaux de
Paris. Intravenous immunoglobulin therapy for pure red cell aplasia
related to human parvovirus B19 infection: A retrospective study of
10 patients and review of the literature. Clin Infect Dis.
56:968–977. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Verhelst D, Rossert J, Casadevall N,
Krüger A, Eckardt KU and Macdougall IC: Treatment of
erythropoietin-induced pure red cell aplasia: A retrospective
study. Lancet. 363:1768–1771. 2004.PubMed/NCBI View Article : Google Scholar
|
